Schedule 13G ownership disclosure

ARIDIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 040334104

Event date: 2021-03-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
676,859
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001349205-21-000006
Form type
SC 13G
Filer
Aridis Pharmaceuticals, Inc.
CIK
CIK 1614067
Filed
Apr 01, 2021
Reporting period
Mar 17, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub